-
Signature
-
/s/ Brian Grube, Attorney-in-Fact
-
Stock symbol
-
INTA
-
Transactions as of
-
Jan 8, 2025
-
Transactions value $
-
-$1,157,122
-
Form type
-
4
-
Date filed
-
1/10/2025, 04:12 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
INTA |
Common Stock |
Options Exercise |
$79.8K |
+20K |
+2.41% |
$3.99 |
848K |
Jan 8, 2025 |
Direct |
F1 |
transaction |
INTA |
Common Stock |
Sale |
-$12.2K |
-200 |
-0.02% |
$60.89 |
848K |
Jan 8, 2025 |
Direct |
F1, F2 |
transaction |
INTA |
Common Stock |
Sale |
-$920K |
-15K |
-1.76% |
$61.51 |
833K |
Jan 8, 2025 |
Direct |
F1, F2 |
transaction |
INTA |
Common Stock |
Sale |
-$185K |
-2.96K |
-0.35% |
$62.72 |
830K |
Jan 8, 2025 |
Direct |
F1, F2 |
transaction |
INTA |
Common Stock |
Sale |
-$120K |
-1.89K |
-0.23% |
$63.25 |
828K |
Jan 8, 2025 |
Direct |
F1, F2 |
holding |
INTA |
Common Stock |
|
|
|
|
|
35K |
Jan 8, 2025 |
By Spouse |
F3 |
holding |
INTA |
Common Stock |
|
|
|
|
|
15K |
Jan 8, 2025 |
By Trust |
F4 |
holding |
INTA |
Common Stock |
|
|
|
|
|
15K |
Jan 8, 2025 |
By Trust |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
INTA |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-20K |
-28.9% |
$0.00 |
49.2K |
Jan 8, 2025 |
Common Stock |
20K |
$3.99 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: